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IN this study, we investigated the expression of
lipocortin I and II (annexin I and I in the
human bronchial epithelium, both in vivo and in
vitro. A clear expression of lipocortin I and II
protein was found in the epithelium in sections
of bronchial tissue. In cultured human bronchial
epithelial cells we demonstrated the expression
of lipocortin I and II mRNA and protein using
Northern blotting, FACScan analysis and ELISA.
No induction of lipocortin I or H mRNA or
protein was observed after incubation with dexa-
methasone. Stimulation of bronchial epithelial
cells with IL-I, TNF- or LPS for 24h did not
affect the lipocortin I or H mRNA or protein
expression, although PGE2 and 6-keto-PGFl pro-
duction was significantly increased. This IL-I-
and LPS-mediated increase in eicosanoids could
be reduced by dexamethasone, but was not
accompanied by an increase in lipocortin I or H
expression. In human bronchial epithelial cells
this particular glucocorticoid action is not
mediated through lipocortin I or II induction.
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Introduction
The bronchial epithelium is considered to play
an important role in initiating and perpetuating
inflammatory and immunological reactions by
production of a variety of inflammatory media-
tors. Therefore, it is thought that human bron-
chial epithelial cells (HBEC) may play a role in
inflammatory pulmonary diseases such as asthma.
Upon in vitro stimulation with inflammatory
agents such as interleukin-l[ (IL-113), tumour
necrosis factor-a (TNF-a) and lipopolysaccharide
(LPS), HBEC are able to produce several cyto-
kines, such as IL-1, interleukin-6 (IL-6), inter-
leukin-8 (IL-8), granulocyte-macrophage colony-
stimulating factor (GM-CSF) and monocyte che-
moattractant factor-1 (MCP-1).-
Furthermore,
HBEC exposed to various stimuli in vitro release
several arachidonic acid metabolites, including
15-hydroxyeicosatetraenoic acid (15-HETE),
prostaglandin E2 (PGE2) and 6-keto-prosta-
glandin F= (6-keto-PGFa).4’5 In addition to
these pro-inflammatory properties, HBEC could
also be involved in anti-inflammatory reactions
through the production of potential anti-inflam-
matory proteins, e.g. lipocortins.
Lipocortin I and II (annexin I and II) are
members of the annexin family of Cai+-depen
dent phospholipid-binding proteins. Biological
evidence suggests that at least some members of
this family are glucocorticoid inducible proteins
with anti-inflammatory properties7 It has been
proposed that lipocortins I and II mediate part of
the immunosuppressive activity of glucocorti-
coids by inhibiting phospholipase A2 (PLA2)
activity, hereby preventing eicosanoid produc-
tion.
8 In some recent studies, however, the
induction of lipocortin I and II by glucocorti-
coids was not obseeeed.9-11 Other biological
functions for lipocortins have also been reported,
such as the regulation of cell differentiation and
growth, and a role in the central nervous system
and neuroendocrine system (reviewed in Refer-
ence 12).
Animal studies have suggested that the lung is
a rich source of lipocortin I.13-16 In the human
lung, lipocortin synthesis has been described in
blood leucocytes and alveolar macrophages.7’
In cultured human tracheal submucosal gland
cells production of lipocortin-like proteins have
been found.19 However, to our knowledge, no
data are available on the presence of lipocortins
in HBEC.
The aim of this study was to investigate the
expression of lipocortin I and II in HBEC and in
the human bronchial epithelial cell line BEAS 2B,
and to examine whether these potential anti-
inflammatory proteins could, be induced by
glucocorticoids. Furthermore, we investigated the
effect of inflammatory agents such as IL-I, TNF-
a and LPS on the lipocortin expression. Finally,
we studied whether the effects of dexamethasone
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on the IL-113- and LPS-stimulated production of nectin (10 lag/ml; Central Laboratory of the
PGE2 and 6-keto-PGFx correlated with an induc- Blood Transfusion Service, Amsterdam, The
tion of lipocortin I and II. Netherlands), collagen (Vitrogen 100, 30 l.tg/ml;
Collagen Corp., Palo Alto, CA) and bovine serum
albumin (BSA) (10 btg/iiml; Boehringer, Mann- Materials and Methods heim, Germany) in PBS. Before using the BEAS
Isolation and culture conditions of HBEC.. 2B cells for experiments, cells were cultured for
Bronchi were obtained from patients undergoing one passage in DMEM/F12 with supplements, as
surgery for lung cancer. Only bronchial tissue described for HBEC cells.
distant from the tumour and having a normal
macroscopic appearance was used. Freshly Immunofluorescence and immunoperoxidase
removed tissue samples were collected in cold stainings of cells and tissue: Immunostainings
sterile HEPES buffered RPMI (GIBCO, Paisley, were performed with a rabbit polyclonal anti-
UK), supplemented with penicillin G sodium body against lipocortin I, kindly provided by Dr
(100 U/ml; Gist-Procades, Delft, The Nether- R.B. Pepinsky and a mouse monoclonal anti-
lands) and streptomycin sulphate (0.1 mg/ml; body against lipocortin II (Oncogene Science
Biochrom KG, Berlin, Germany) for transport to Inc., Manhasset, NY). All antibody reagents were
the laboratory. Tissue samples were cut into diluted in PBS containing (w/v) 0.5% BSA and
pieces, washed with cold phosphate buffered 0.1% sodium azide. Normal mouse serum,
saline (PBS), and incubated either overnight at normal rat serum and two subclass specific anti-
4C or l h at 37C in HEPES buffered RPMI bodies were used as negative controls.
containing 0.1% protease XlV (Sigma, St Louis,
MO), penicillin G sodium (100 U/ml) and strep- Cells. For fluorescence activated cell scan
tomycin sulphate (0.1 mg/ml). Subsequently, (FACScan) experiments cells were detached with
epithelial cells were gently scraped from the 0.02% EDTA, fixed for 40 min at room tempera-
tissue samples, washed twice in culture medium ture (RT) with Permea-Fix Reagent (Ortho Diag-
and plated onto 35-mm dishes at a density of nostic Systems, Beerse, Belgium)and washed for
2.5 x 105 cells/dish. 10 min with PBS/BSA (0.5%). The cells were
HBEC were cultured in a 1:1 mixture of Dul- then incubated with anti-lipocortin I or II anti-
becco’s modified Eagle’s medium and Ham’s F12 bodies for 30 min on ice. After washing with
(DMEM/F12) (GIBCO), supplemented with PBS/BSA, cells were incubated for another 30
insulin (0.01 mg/ml; Sigma), hydrocortisone (1 min with either fluorescein isothiocyanate
I.tg/ml; Pharma Chemie, Haarlem, The Nether- (FITC)-conjugated goat anti-rabbit-IgG against
lands), transferrin (0.01 mg/ml; Behring Marburg, lipocortin I or FITC-conjugated goat anti-mouse-
Germany), epidermal growth factor (EGF) (10 IgG against lipocortin II. Subsequently, the cells
ng/ml; Collaborative Research Inc., Lexington, were washed and staining was analysed and
MA), foetal calf serum (FCS)(1%), Na2SeO3 (50 quantified using a FACScan flow cytometer
nM), glutamine (1 mM; JT Baker bv., Deventer, (Becton Dickinson).
The Netherlands), penicillin G sodium and strep-
tomycin sulphate (0.1 mg/ml). Cells were char- Tissue. Bronchi specimens for immunohisto-
acterized as epithelial cells by immuno- chemistry, from one female and two male non-
fluorescence staining using a mouse monoclonal asthmatic patients, were quickly frozen in liquid
antibody directed against a number of human nitrogen and stored at -80C. Six lam frozen
cytokeratins (CK-1; DAKOpatts, Glostrup, bronchi sections were fixed in acetone for 1 min
Denmark). At least 99% of the isolated cells at RT and incubated with anti-lipocortin I or II
stained positive for cytokeratin (n 5). antibodies for 60 min in a humidified chamber.
The sections were then washed twice with PBS/
Human bronchial epithelial cell line: BEAS 2B is Tween (0.1%) and incubated for 60 min with
a SV-40 transformed human bronchial epithelial horseradish peroxidase (HRP)-conjugated swine
cell line, which was kindly provided by Dr J. anti-rabbit-IgG or HRP-conjugated rabbit anti-
Lechner (Inhalation Toxicology Research Insti- mouse-IgG for detection of lipocortin I and II,
tute, Albuquerque, NM).
2 Cells were maintained respectively (DAKOpatts). After three washing
in a keratinocyte growth medium containing procedures with PBS/Tween, peroxidase activity
bovine pituitary extract, EGF, penicillin G sodium was measured using diaminobenzidine tetra-
and streptomycin sulphate (KGM; GIBCO).
21 hydrochloride (Sigma)as substrate.
Plastic cell culture plates (Falcon, Becton Dick-
inson, NJ) were precoated as described by Stimulation experiments with IL-I, TNF and
Lechner et al. with a mixture of human fibro- LPS in the presence of dexamethasone: All
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experiments were performed on days 7 through dehydrogenase (GAPDH) probe was a 0.7 kb
10 of primary culture of HBEC. Twenty-four h EcoRI-PstI fragment.
25 The IL-8 probe was a 1.3
before treatment with cytokines and/or dex- kb EcoRI fragment, kindly provided by Dr T. J.
amethasone the medium was replaced by a basal Stoof (Department of Dermatology, VU Hospital,
medium consisting of DMEM/F12 without hydro- Amsterdam, The Netherlands).
cortisone or other supplements to prevent influ- The intensity of the lipocortin I, lipocortin II,
ence of endogenous steroids. IL-I (20 ng/ml; IL-8 and GAPDH mRNA signals on the auto-
UBI, Lake Placid, NY), TNF-a (20 ng/ml; UBI), radiograph were scanned with a handscanner
LPS (10 or 100 btg/ml; Difco Laboratories, Detroit, (Colorscanner 2,
24 Highscreen, WCrselen,
MI) and/or dexamethasone (10-
M; Duchefa bv., Germany) at a resolution of 100 dots per inch.
Haarlem, The Netherlands) were added to the Computer software described by Koning et al.
basal medium. After 24 h, supernatants were was used to analyse the intensity of the bands.2
collected. Total RNA was isolated as described Values were expressed as the ratio of lipocortin
below. Supernatants and RNA were stored at to GAPDH mRNA intensity.
-20C and-80C, respectively, until analysis.
Analysis of extracellular lipocortin I in culture
RNA isolation, Northern blot analysis and supernatants: Extracellular lipocortin I levels
probes.. Total RNA was extracted as described were kindly measured b: Dr Susan F. Smith,
previously and stored at -80C until used.2 using a competitive ELISA.
7
Northern blotting and hybridization were per-
formed as described previously.
24 The lipocortin Production of arachidonic acid metabolites.. The
I and II probes were a 1.3 and a 0.9 kb EcoRI arachidonic acid metabolites PGE2 and 6-keto-
fragment, respectively, kindly provided by PGFla were measured by radioimmunoassay as
Dr B. P. WaRner (Biogen Research Corp., Cam- described previously,
is Arachidonic acid metabo-
bridge, MA). The glyceraldehyde-3-phosphate- lite release was normalized to total RNA content.
FIG. 1. Immunoperoxidase staining for lipocortin (upper panel) and II (lower panel) of frozen sections of human bronchi. Left: magnifi-
cation 6.3 x. Right: magnification 40 x.
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Statistical analysis.. The Mann-Whitney U test
was used to assess significant differences in PGE2
and 6-keto-PGFla production, and in lipocortin I
and II mRNA expression in cell cultures under
different conditions of incubation. A p-value of
less than 0.05 was considered significant.
Results
Lipocortin I and II expression in vivo: Immuno-
peroxidase staining of bronchi sections (n 3)
with anti-lipocortin I and II antibodies showed a
strong expression in the bronchial epithelium
(Fig. 1). Similar staining patterns were observed
for lipocortin I and II. Positive staining for lipo-
cortin I and II was also found in the epithelial
cells of the submucosal glands.
Lipocortin I and II expression in vitro: In
cultured HBEC and in BEAS 2B cells lipocortin
expression was studied using FACScan and
Northern blot analysis. With FACScan analysis
we found that more than 99% of BEAS 2B
cells were positive for both intracellular lipo-
cortin I and II (Fig. 2). Fifty and 80% of cultured
HBEC (n 3) were positive for intracellular
lipocortin I and II, respectively. A representative
experiment is shown in Fig. 2. Northern blot
analysis showed expression of lipocortin I and
II mRNA, 1.4 and 1.6 kb respectively, in both
cultured HBEC and BEAS 2B cells (Figs 3A and
).
A
Effects of IL-I, TNF-a, LPS and dexamethasone
on lipocortin I and II mRNA and protein
BEAS 2B BEAS 2B HBEC HBEC
Fluorescence intensity
FIG. 2. FACS analysis of intracellular lipocortin (A,C) and II (B,D) expressions in BEAS 2B cells and in HBEC. Representative histo-
grams, indicating nonspecific fluorescence intensity (thin line) and lipocortin or II expression (bold line) are shown.
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FIG. 3. Effects of IL-1]3, TNF-, LPS and dexamethasone on lipocortin and II mRNA expression. Northern blot analysis of HBEC (A) and
BEAS 2B cells (B). HBEC from three different patients were cultured for 24h in a basal medium of DMEM-/F12 (lanes 1,6,12), with
10
-6 M dexamethasone (lanes 2,7,13), with 20 ng/ml IL-I (lanes 3,8,14), with 20 ng/ml TNF-t (lanes 4,9,15), with 100 btg/ml LPS
(lanes 5,10,16), or with 100 lag/ml LPS and 10
-6 M dexamethasone (lanes 11,17). BEAS 2B cells were cultured for 24h in DMEM/
F12 supplemented with insulin, hydrocortisone, transferrin, EGF and FCS (lane 1), in a basal medium of DMEM/F12 (lane 2), with 10
lg/ml LPS (lane 3), with 10 pg/ml LPS and 10
-6 M dexamethasone (lane 4), with 20 ng/ml IL-I (lane 5), or with 20 ng/ml IL-I[
and 10
-6 M dexamethasone (lane 6). The filters were hybridized to 32p-labelled lipocortin (LCT-1), lipocortin II (LCT-2), IL-8 and
GAPDH probes.
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FIG. 4. Effect of 24h incubation with IL-I (20 ng/ml), TNF (20 ng/ml), LPS (100 lg/ml) and dexamethasone (10
-6 M) on the basal
lipocortin mRNA expression and the basal release of PGE2 and 6-keto-PGFl in cultures of HBEC (n 5). PGE2 and 6-keto-PGFl=
release and lipocortin mRNA expression are expressed relative to the basal production. Lipocortin mRNA expression was corrected
for GAPDH mRNA expression. Median values are represented by a (+).
expression: To investigate the effect of inflam- Effects of lL-I, TNF4x, LPS and dexamethasone
matory age and dexamethasone on lipocortin I on PGE2 and 6-keto-PGFlu production, and
and II mRNA and protein expression, HBEC and correlation with lipocortin mRNA expression:
BEAS 2B cells were incubated with different The effect of IL-1], TNF-a, and LPS on PGE2
concentrations of IL-1], TNF-a, LPS and dexa- and 6-keto-PGFl production was measured,
methasone. Incubation for 24h with IL-1], and we studied whether the expected inhibition
TNF-a, LPS or dexamethasone did not sig- of stimulated eicosanoid production by dexa-
nificantl affect lipocortin I or II mRNA expres- methasone correlated with an induction of lipo-
sion in cultured HBEC or in BEAS 2B cells (Figs cortin I and II. Incubation of HBEC (n 5)
3A and 3B). IL-8 mRNA was used as a positive for 24h with either IL-I[, or TNF-a or LPS sig-
control, as it has been shown previously to nificantly increased basal PGE2 and 6-keto-
increase upon stimulation with IL-1] or LPS, and PGFI production (p < 0.01) (Fig. 4). PGE2
to decrease upon incubation with dexa- and 6-keto-PGF production in one representa-
methasone. Figure 3B shows that IL-8 mRNA tive culture of HBEC is shown in Table 1. The
expression in BEAS 2B cells was decreased after LPS- and IL-1]-mediated increases in PGE2 and
incubation with dexamethasone, whereas lipo- 6-keto-PGFa production were reduced by dexa-
cortin I mRNA expression was not increased. The methasone. Reduction of the LPS-mediated
results of the experiments (n 5), in which the increase of PGE2 by dexamethasone was statist-
effects of IL-1], TNF-a, LPS and dexamethasone ically significant (p < 0.05). Dexamethasone
on the basal lipocortin I mRNA expression in also clearly reduced the IL-1l-mediated increase
cultures of HBEC were studied, is shown in of both PGE2 and 6-keto-PGF, but statistical
Fig. 4. Using FACScan analysis and ELISA no significance could not be reached because of
effect of IL-1], TNF-a, LPS or dexamethasone low sample number. Reduction of the IL-I[-
was observed on the lipocortin I or II protein and LPS-mediated PGE2 and 6-keto-PGF
expression in HBEC or BEAS 2B cells (data not production by dexamethasone was not
shown), accompanied by an increase in lipocortin
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Table 1. PGE2 and 6-keto-PGF,a production in a representative reduced by dexamethasone. Reduction by dexa-
culture of HBEC methasone of the stimulated production of PGE2
Stimulation condition PGE2 6-keto-PGF .and 6-keto-PGF was not accompanied by an
increase in lipocortin I or II expression. Thus,
Basal 5.68 1.60 in HBEC this particular glucocorticoid action Dex 3.43 1.42
LPS 8.98 4.68 is not mediated through lipocortin I or II induc-
kPS + Dex 7.50 1.45 tion.
IL-11 16.51 3.25 Our findings on the expression of lipocortin I IL-118+Dex 7.31 2.29
TNF- 7.71 2.60 in the human bronchus are in agreement with
those in the airway epithelium of the rat, studied
HBEC were incubated for 24 h with IL-11 (20 ng/ml), TNF- (20 ng/ml),
LPS (100 gg/ml) and dexamethasone (Dex)(10
-6 M). by Fava et al.29 They demonstrated the presence
bpGE2 and 6-keto-PGFl= production are expressed as ng.ml-l.mg total of lipocortin I in the rat epithelium of nasal,
NA. tracheal and bronchial airways, and in the ductal
epithelium of various glands. Production of lipo-
mRNA (Fig. 4) or lipocortin II mRNA (data not cortin-like proteins in cultured human tracheal
shown), submucosal .land cells has been described by
Jacquot eta/. 9 In the foetal and neonatal human
Analysis of the inducibility of lipocortin I and II lung, lipocortin I immunostaining was found in
mRNA by dexamethasone: To evaluate the effect the bronchiolar epithelium as early as 12 weeks,
of dexamethasone on lipocortin I and II mRNA beginning with the largest airways, and by 24
expression more precisely we cultured HBEC weeks extending distally to the bronchioloalveo-
and BEAS 2B cells for up to 5 days without lar portals. In bovine bronchial epithelial cells a
glucocorticoids. The cells were then incubated differential expression of lipocortin I and II was
with different concentrations of dexamethasone found.1 Lipocortin I was expressed in the cili-
(10-, 10-9, 10-8, 10-7, and 10-
M) and with ated cells, whereas lipocortin II was expressed in
105 M dexamethasone for various lengths of the basal cells. We did not find such a differential
times (2, 4, 6, 10, 24 and 48h). Both the effects expression of lipocortin I and II in human
of dexamethasone on cells cultured in a bronchi in our studies.
medium of DMEM/F12 without supplements and The bronchial epithelium is considered to play
on cells in a medium of DMEM/F12 supple- an important role in inflammatory and immuno-
mented with insulin, transferrin, EGF, NaiSeO, logical reactions by production of a variety of
and charcoal-stripped FCS, but without hydro- inflammatory mediators as can be obseeeed in
cortisone were examined. Under none of these inflammatory pulmonary diseases such as asthma.
conditions dexamethasone affected the expres- In addition to this role, the bronchial epithelium
sion of lipocortin I or II mRNA (data not could also be involved in anti-inflammatory reac-
shown), tions through the production of anti-inflamma-
tory proteins, e.g. lipocortins. In this study we
found a high expression of lipocortin I and II in Discussion the human bronchial epithelium. A physiological
We demonstrated in this study that lipocortin role has been proposed for lipocortin I recently.
and II are expressed in cultured HBEC, a Lipocortin I may function as a ’barrier’ to inap-
bronchial epithelial cell line and in the epithe- propriate inflammatory and autoimmune respon-
lium in bronchi sections. Immunoperoxidase ses at specific sims around the body.
7 Following
stainings of human bronchi sections with anti- an inflammatory stimulus, stress-induced stimula-
lipocortin I and II antibodies showed a clear tion of the hypothalamic-pituitary-adrenal axis
expression in the bronchial epithelium and in (HPA) axis may result in the release of cortisol,
the epithelial cells of the submucosal glands. In which in turn leads to the production of lipo-
cultured HBEC and in the BEAS 2B cell line, we cortin I. The lipocortin-binding molecules on
demonstrated the presence of lipocortin I and II monocytes and neutrophils arriving at tissue sims
mRNA and protein by Northern blotting and are expected to become saturated, with resultant
FACScan analysis, respectively. Lipocortin I and II moderation of migratory and/or pro-inflamma-
mRNA and protein expression in the HBEC was tory activities. Others have speculated from
not affected by incubation of the cells with IL- results in animal studies that epithelial cell
113, TNF-a, LPS or dexamethasone. The HBEC damage and loss, as seen in asthmatics, could
were able to respond to these stimuli, as the decrease availability of these protective properties
production of PGE2 and 6-keto-PGFl signifi- of lipocortin I.1 Increased inflammation would
cantly increased upon incubation with IL-113, thereby be predicted.
TNF-a or LPS. This increased production was We did not observe an induction of lipocortin
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I or II by dexamethasone in cultures of HBEC or
in the BEAS 2B cell line. An elevated production
of lipocortin I in response to glucocorticoids has
been demonstrated in human peripheral blood
monocytes, human alveolar macrophages, rat
alveolar epithelial cells and in bovine bronchial
epithelial cells,x5-x8 Glucocorticoids increased
amounts of lipocortin I in these cells in a dose
dependent manner. However, Br6nnegard et al.
did not observe an induction of lipocortin I
mRNA by dexamethasone in seven different cell
types, including primary human macrophages,xx
The synthesis of lipocortin I does not appear to
be under glucocorticoid control in certain cell
lines and has been linked with cell differentiation
events in some cases.7’’2 Isacke et al. were
unable to observe any effect of dexamethasone
treatment in U-937 cells under a variety of condi-
tions on the expression of lipocortin I or II, nor
did dexamethasone induce their secretion,x An
induction by dexamethasone of the expression
of mRNA of lipocortin I and II and the release of
lipocortin I and V was observed in differentiated,
but not in undifferentiated U-937 cells by Sollito
et al.32
For the induction experiments we used both
HBEC, just a few days after isolation and after
culturing for 1 or 2 weeks. Other studies point to
the importance of culture conditions in studying
synthesis of lipocortins by cultured cells.3x In our
experiments we have used charcoal-stripped FCS
in the culture medium so that endogenous
steroids, which might influence lipocortin syn-
thesis, are removed. We have incubated epithelial
cells for up to 5 days in steroid-free medium
prior to the addition of dexamethasone, to
ensure that the cells were in an unstimulated
condition at the beginning of the experiment. As
growth factors, such as EGF, are thought to
induce lipocortin synthesis, we have also per-
formed experiments, in which cells were cultured
in a basal medium without growth factors. In all
cases we found a clear mRNA and protein
expression of lipocortin I and II in HBEC, but no
induction of lipocortins by dexamethasone after
incubation for various lengths of times with dif-
ferent concentrations. After culturing for 5 days
in steroid free medium, lipocortin I mRNA was
expressed constitutively at approximately 90% of
the lipocortin I mRNA level in complete medium,
containing hydrocortisone. Vishwanatha et al.
found in bovine bronchial epithelial cells, that
the constitutive expression of lipocortin I was
20% of the lipocortin I level in medium contain-
ing hydrocortisone after culturing for 5 days.
x6
These studies indicate that there is a difference
between species in the inducibility of lipocortins
by glucocorticoids.
In summary, we found a high expression of
lipocortin I and II in the bronchial epithelium
compared to the underlying layers in human
bronchi sections and demonstrated that gluco-
corticoids do not increase the expression of
lipocortin I and II in HBEC. Our study indicates,
that decrease in PGE2 and 6-keto-PGFl produc-
tion in HBEC upon incubation with glucocorti-
coids is not mediated by increased expression of
lipocortins.
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